Seema S. Aceves

Seema S. Aceves

Auto-generated profile, based on publicly available information

Seema S. Aceves

Division of Allergy and Immunology, University of California, San Diego, California, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SASeema S. Aceves
Seema S. Aceves
DCDiana Chen
Diana Chen
RNRobert O. Newbury
Robert O. Newbury
RDRanjan Dohil
Ranjan Dohil
JBJohn F. Bastian
John F. Bastian
DBDavid H. Broide
David H. Broide

1 January 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
NGNirmala P. Gonsalves
Nirmala P. Gonsalves
SASeema S. Aceves
Seema S. Aceves

1 June 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IOIris M. Otani
Iris M. Otani
AAArjun A. Anilkumar
Arjun A. Anilkumar
RNRobert O. Newbury
Robert O. Newbury
MBMonica Bhagat
Monica Bhagat
LBLisa Y. Beppu
Lisa Y. Beppu
SASeema S. Aceves
Seema S. Aceves

1 June 2014 in Gastroenterology Clinics of North America
Verified
Journal Article
Closed access
IHIkuo Hirano
Ikuo Hirano
SASeema S. Aceves
Seema S. Aceves

28 February 2014 in Digestive Diseases
Verified
Journal Article
Closed access
PDF file
SASeema S. Aceves
Seema S. Aceves
Chronic eosinophilic inflammation has been associated with tissue remodeling in a number of disease states including the hypereosinophilic syndrome (HES), asthma, and, more recently, eosinophilic esophagitis (EoE). Remodeling occurs in the epithelial and subepithelial esophageal tissue, and includes basal zone hyperplasia, epithelial mesenchymal transition, fibrosis, angiogenesis, and smooth muscle hypertrophy/hyperplasia. Previously, research on the clinical impacts of tissue remodeling has been limited by a paucity of human tissue. However, in EoE, recurrent biopsies are required for diagnosis and management. As such, investigators are able to study the associations between tissue changes and clinical disease features. A number of profibrotic and proangiogenic factors are elevated in EoE, including TGF-β1, CCL-18, FGF-9, VEGF, and VCAM-1. Both eosinophils and mast cells produce a number of these factors. TGF-β1 appears to be a master regulator of end-organ dysfunction in EoE and can cause esophageal epithelial mesenchymal transition, fibrosis, and smooth muscle contraction. The requirement for eosinophils, the eosinophilopoietic interleukin, IL-5, and the canonical TGF-β1 signaling pathway for EoE-associated fibrosis, has been invoked using gene-deficient mice. The clinical consequences of eosinophil-associated tissue fibrosis can be devastating, such as endomyocardial fibrosis and heart failure in HES. In EoE, tissue remodeling appears to be the mechanism for multiple cardinal disease complications including esophageal rigidity, strictures, narrowing, and food impactions, as well as the clinical hallmark of dysphagia. Therapies that may be able to reduce or reverse EoE-associated remodeling include topical corticosteroids, anti-IL-5, and food antigen avoidance.

1 July 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
JSJonathan Spergel
Jonathan Spergel
SASeema S. Aceves
Seema S. Aceves